GHK-Cu Peptide: What It Is, Benefits, Research and Safety

Peptide Guides

What Is GHK-Cu Peptide?

GHK-Cu is a copper complex of the tripeptide glycyl-L-histidyl-L-lysine. A peptide is a short chain of amino acids, and at three links GHK is one of the shortest peptides studied anywhere; our introduction to peptides starts from the beginning. GHK was first isolated from human plasma in the early 1970s by the biochemist Loren Pickart, who noticed that plasma from young donors did something to aged liver cells that plasma from older donors did not, and traced the activity to this small peptide.²

GHK binds copper(II) ions with very high affinity, and most of its studied biology involves the copper-loaded form rather than the bare peptide.³ The complex gives solutions a characteristic deep blue colour, which is why mixed GHK-Cu is visibly blue where almost every other research peptide solution is colourless.

How Does GHK-Cu Work in the Body?

GHK occurs naturally in human plasma, saliva and urine. Published reviews report that plasma GHK concentrations, measured as the free peptide rather than the copper complex, decline with age from approximately 200 ng/ml in young adults to around 80 ng/ml by age 60.¹ That observation is one reason the molecule attracts interest in ageing research, and it does not establish that raising GHK or GHK-Cu levels improves health or reverses ageing.

The body appears to release GHK from larger proteins when tissue is damaged: it is described as a matricryptin, a fragment cut loose from collagen and the matrix protein SPARC during injury and remodelling.⁶ On that account, GHK is part of the body's own damage-response signalling, and the research question is what the signal does.

One person's work shaped this whole field. Loren Pickart discovered GHK, patented uses of it, founded a company selling copper-peptide skincare, and wrote the major reviews of its biology.^2,3 His reviews are the standard starting point for the mechanism literature, and they are also the work of the field's chief advocate, so this guide uses them for background and relies on independent studies for outcome claims.

GHK-Cu Benefits: What Does Research Suggest?

In laboratory and animal studies, GHK-Cu has been linked to collagen, elastin and glycosaminoglycan synthesis in skin cells, support of dermal fibroblasts, new blood-vessel growth, and wide-ranging modulation of gene expression.^2,3 Animal studies have reported faster healing of open wounds in rats and rabbits with topical application,^7,8 a transient improvement in ligament graft healing in rats given intra-articular injections, a benefit that was present at six weeks and gone by twelve,⁹ and protective effects in mouse models of acute lung injury.¹⁰

Two features recur across this work. The effects centre on tissue repair and the structures that hold skin together, which is why the cosmetic industry adopted the molecule. And nearly all of it happened in cells and animals; animal vs human peptide research explains why that distinction decides what a finding can support.

GHK-Cu Human Studies: What Does the Evidence Show?

The human record is small, topical and mixed. A randomised trial of GHK-Cu skincare after CO2 laser resurfacing found no objective improvement in redness or wrinkles against controls, although patients using it rated their skin quality higher.⁴ An earlier randomised trial in venous leg ulcers found a GHK-Cu cream performed no better than placebo, and worse than a standard comparator cream.⁵ A 2026 systematic review of the field concluded that the human literature remains thin and fragmented, made up mostly of small facial-cosmetic trials, with not one adequately powered registered human trial of the delivery methods the preclinical work points to.⁶

No published human trial has tested injected GHK-Cu on its own, and a 2026 scoping review in the American Journal of Sports Medicine found no human data for GHK-Cu in musculoskeletal use at all.¹¹ For the trial-by-trial walkthrough, see Does GHK-Cu work? GHK-Cu side effects and safety covers what the same record means for safety.

GHK-Cu Forms: Topical Cosmetics and Research Vials

GHK-Cu is unusual among research peptides because it has a large, lawful consumer market running alongside the research one. Under the cosmetic ingredient name Copper Tripeptide-1 it appears in serums, creams and hair products, where it is regulated as a cosmetic and marketed on appearance. The research market sells the same molecule as lyophilised (freeze-dried) powder in vials, labelled by nominal peptide content, for laboratory use.

The two forms raise different questions. Topical products face a delivery problem, because a small water-loving peptide crosses the skin's outer barrier poorly, and much current research concerns carriers designed to get it through.^12,13 Research vials raise the questions this site's guides cover for every compound: what the label figure means, what a certificate of analysis covers, and what the law says. GHK-Cu topical vs injectable compares the two forms in full, and GHK-Cu quantities covers the vial arithmetic.

Common Questions About GHK-Cu

Is GHK-Cu natural?

Yes, as a molecule. GHK occurs naturally in human plasma, saliva and urine, bound to copper.^1,3 Products containing it are made synthetically, and a natural origin says nothing about whether supplementing it does anything.

Has GHK-Cu been tested on humans?

Only in small topical trials, with mostly equivocal results.^4,5,6 No published human trial has tested injected GHK-Cu on its own.

Is the GHK-Cu in skincare the same molecule as in research vials?

Yes: Copper Tripeptide-1, the cosmetic ingredient name, is the same glycyl-L-histidyl-L-lysine copper complex. The products differ in form, concentration, regulation and what may lawfully be claimed about them.

Why is GHK-Cu blue?

The colour comes from the copper. Copper(II) complexes absorb light in a way that makes their solutions blue, so dissolved GHK-Cu is visibly blue where most peptide solutions are colourless. The colour indicates the copper complex, not quality or strength.

Is GHK-Cu legal in the UK?

As a cosmetic ingredient, yes. As an injectable or any product for use in the body, it is not an approved medicine and cannot be sold for human use; supply for laboratory research is lawful under research-use-only conditions. Is GHK-Cu legal in the UK? has the full position.

GHK-Cu Research Peptide: Product Specification

We supply GHK-Cu as lyophilised powder in sealed 5mg and 10mg vials labelled by nominal peptide content. Each batch is purity-tested by HPLC and identity-confirmed by mass spectrometry, with a dated certificate of analysis published per batch. View our GHK-Cu research peptide product for the current batch specification and certificate of analysis.

Supplied for laboratory research use only. Not for human consumption.

References

1. Dou Y, Lee A, Zhu L, Morton J, Ladiges W. The potential of GHK as an anti-aging peptide. Aging Pathobiol Ther. 2020;2(1):58-61. DOI
2. Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. 2015;2015:648108. DOI
3. Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018;19(7):1987. DOI
4. Miller TR, Wagner JD, Baack BR, Eisbach KJ. Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin. Arch Facial Plast Surg. 2006;8(4):252-9. DOI
5. Bishop JB, Phillips LG, Mustoe TA, et al. A prospective randomized evaluator-blinded trial of two potential wound healing agents for the treatment of venous stasis ulcers. J Vasc Surg. 1992;16(2):251-7. DOI
6. Najafi N, Maatouk H, Vardanyan KG, Vartanian KB, Agrawal DK. A Systematic Review of the Mechanisms and Therapeutic Applications of GHK-Cu in Topical Microneedle Delivery. Arch Intern Med Res. 2026;9(3):269-293. DOI
7. Canapp SO, Farese JP, Schultz GS, et al. The effect of topical tripeptide-copper complex on healing of ischemic open wounds. Vet Surg. 2003;32(6):515-23. DOI
8. Cangul IT, Gul NY, Topal A, Yilmaz R. Evaluation of the effects of topical tripeptide-copper complex and zinc oxide on open-wound healing in rabbits. Vet Dermatol. 2006;17(6):417-23. DOI
9. Fu SC, Cheuk YC, Chiu WY, Yung SH, Rolf CG, Chan KM. Tripeptide-copper complex GHK-Cu (II) transiently improved healing outcome in a rat model of ACL reconstruction. J Orthop Res. 2015;33(7):1024-33. DOI
10. Park JR, Lee H, Kim SI, Yang SR. The tri-peptide GHK-Cu complex ameliorates lipopolysaccharide-induced acute lung injury in mice. Oncotarget. 2016;7(36):58405-58417. DOI
11. Tewari K, Liu TP, Im C, et al. Peptide Supplements and Their Therapeutic Applications in Sports Medicine. Am J Sports Med. 2026. DOI
12. Mortazavi SM, et al. Topically applied GHK as an anti-wrinkle peptide: Advantages, problems and prospective. Bioimpacts. 2024;14(6):30071. DOI
13. Ogórek N, et al. Are We Ready to Measure Skin Permeation of Modern Antiaging GHK-Cu Tripeptide Encapsulated in Liposomes? Molecules. 2025;30(1):136. DOI